STAT3 and neoplasm: Western analysis on tumour lysates showed that NVP-AST487 treatment alone, or combined with fulvestrant or tamoxifen caused a significant decrease in the pY705-Stat3/Stat3 ratio compared to controls; neither of the endocrine agents alone affected pY705Stat3 levels (Fig 6A and Supporting Information Fig S5D).